Cargando…

Impact of multiplicity of functional KIR-HLA compound genotypes on hepatocellular carcinoma

Natural killer (NK) cells are potential immune components against hepatocellular carcinoma (HCC) after curative hepatectomy. Patients at high risk of HCC recurrence can be identified by quantifying NK cell licensing. Therefore, therapeutic strategies that manipulate NK cell activity may possibly imp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tanimine, Naoki, Ohdan, Hideki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2015
Materias:	Author's View
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4368133/ https://www.ncbi.nlm.nih.gov/pubmed/25949863 http://dx.doi.org/10.4161/2162402X.2014.983765

Ejemplares similares

KIR/HLA immunogenetic background influences the evolution of hepatocellular carcinoma
por: Cariani, Elisabetta, et al.
Publicado: (2013)

Tricking an ancient immune function to eradicate hepatocellular carcinoma
por: Miyazaki, Toru, et al.
Publicado: (2015)

High immunosuppressive burden in advanced hepatocellular carcinoma patients: Can effector functions be restored?
por: Lugade, Amit A, et al.
Publicado: (2013)

YES, a novel therapeutic target in hepatocellular carcinoma
por: Lapouge, Marjorie, et al.
Publicado: (2022)

Cisd2 haploinsufficiency: A driving force for hepatocellular carcinoma
por: Shen, Zhao-Qing, et al.
Publicado: (2018)

A glypican-3-derived peptide vaccine against hepatocellular carcinoma
por: Sawada, Yu, et al.
Publicado: (2012)

Immune surveillance of pre-cancerous senescent hepatocytes limits hepatocellular carcinoma development
por: Yevsa, Tetyana, et al.
Publicado: (2012)

Overcoming HLA restriction in clinical trials: Immune monitoring of mRNA-loaded DC therapy
por: Van Nuffel, An M.T., et al.
Publicado: (2012)

MHC-I genotype drives early immune selection of oncogenic mutations
por: Marty, Rachel, et al.
Publicado: (2018)

Association analysis of KIR/HLA genotype with liver cirrhosis, hepatocellular carcinoma, and NUC freedom in chronic hepatitis B patients
por: Joshita, Satoru, et al.
Publicado: (2021)

Symmetry breaking in human neuroblastoma cells
por: Izumi, Hideki, et al.
Publicado: (2014)

Contribution of regulatory T cells to immunosuppression and disease progression in multiple myeloma patients
por: Raja, Karthick Raja Muthu, et al.
Publicado: (2013)

slanDCs in carcinoma-draining lymph nodes
por: Vermi, William, et al.
Publicado: (2014)

Chemotherapy engages multiple pathways leading to IL-1β production by myeloid leukocytes
por: Antonopoulos, Christina, et al.
Publicado: (2014)

A new approach for cellular immunotherapy of nasopharyngeal carcinoma
por: Smith, Corey, et al.
Publicado: (2012)

Under one roof: The bone marrow survival niche for multiple myeloma and normal plasma cells
por: Nair, Jayakumar R., et al.
Publicado: (2012)

GM-CSF facilitates the development of inflammation-associated colorectal carcinoma
por: Chen, Guojiang, et al.
Publicado: (2014)

Dysregulation of HIF2α and autophagy in renal cell carcinoma
por: Liu, Xian-De, et al.
Publicado: (2014)

Trogocytosis generates acquired regulatory T cells adding further complexity to the dysfunctional immune response in multiple myeloma
por: Brown, Ross, et al.
Publicado: (2012)

Ménage à trois: Sustained therapeutic anti-tumor immunity requires multiple partners in malignant glioma
por: Wainwright, Derek A, et al.
Publicado: (2014)

Essential updates 2018/2019: Liver transplantation
por: Ohira, Masahiro, et al.
Publicado: (2020)

The role of interleukin-10 in the progression of human papillomavirus-associated lung carcinoma
por: Sung, Wen-Wei, et al.
Publicado: (2013)

Targeting HSP90 sensitizes pancreas carcinoma to PD-1 blockade
por: Liu, Jiao, et al.
Publicado: (2022)

Chemotherapy-elicited upregulation of NKG2D and DNAM-1 ligands as a therapeutic target in multiple myeloma
por: Soriani, Alessandra, et al.
Publicado: (2013)

KIR/HLA genotypes confer susceptibility and progression in patients with autoimmune hepatitis
por: Umemura, Takeji, et al.
Publicado: (2019)

Efficient and accurate KIR and HLA genotyping with massively parallel sequencing data
por: Song, Li, et al.
Publicado: (2023)

Colorectal carcinoma infiltration by myeloperoxidase-expressing neutrophil granulocytes is associated with favorable prognosis
por: Hirt, Christian, et al.
Publicado: (2013)

Adaptive immune resistance in HPV-associated head and neck squamous cell carcinoma
por: Pai, Sara I.
Publicado: (2013)

RON promotes the metastatic spread of breast carcinomas by subverting antitumor immune responses
por: Eyob, Henok, et al.
Publicado: (2013)

Chemoimmunotherapy for advanced gastrointestinal carcinomas: A successful combination of gene therapy and cyclophosphamide
por: Malvicini, Mariana, et al.
Publicado: (2012)

PTPN2 as a promoter of colon carcinoma via reduction of inflammasome activation
por: Spalinger, Marianne R., et al.
Publicado: (2018)

Tumor-infiltrating lymphocytes and outcome in Merkel cell carcinoma, a virus-associated cancer
por: Sihto, Harri, et al.
Publicado: (2012)

Epigenetic dysregulation by aberrant metabolism in renal cell carcinoma can be reversed with Ascorbic acid
por: Shenoy, Niraj
Publicado: (2019)

Molecular hallmarks of renal medullary carcinoma: more to c-MYC than meets the eye
por: Msaouel, Pavlos, et al.
Publicado: (2020)

Extracellular vesicles released by ovarian carcinoma contain arginase 1 that mitigates antitumor immune response
por: Sosnowska, Anna, et al.
Publicado: (2019)

Impact of aging in cancer immunotherapy: The importance of using accurate preclinical models
por: Bouchlaka, Myriam N, et al.
Publicado: (2013)

DC vaccine generated by ALA-PDT-induced immunogenic apoptotic cells for skin squamous cell carcinoma
por: Ji, Jie, et al.
Publicado: (2015)

CX3CL1 at the crossroad of EGF signals: Relevance for the progression of ERBB2(+) breast carcinoma
por: Tardáguila, Manuel, et al.
Publicado: (2013)

Unraveling the physiological functions of exosome secretion by tumors
por: Bobrie, Angélique, et al.
Publicado: (2013)

Novel function of STAT1 in breast cancer
por: Zhang, Ming
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_s3clf3sse1rk68prn65bqgu1ii